Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Biogen’s SKYCLARYS becomes first approved treatment for Friedreich’s Ataxia in EU In a landmark decision, the European Commission (EC) has authorized Biogen Inc.’s SKYCLARYS (omaveloxolone) for the treatment of… byPallavi MadhirajuFebruary 13, 2024